Concepedia

Ming‐Jo Hsu

MH

10

Publications

691

Citations

10

H-Index

1991

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Ming‐Jo Hsu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and antifungal agents.

Top concepts

Publications per year

1991–2020

10

Publications

10

Elongation Factor 2 as a Novel Target for Selective Inhibition of Fungal Protein Synthesis

Michael Justice, Ming‐Jo Hsu, Bruno Tse et al. · Journal of Biological Chemistry · 1998 · 190 citations · Full text

Acquired Echinocandin Resistance in a <i>Candida krusei</i> Isolate Due to Modification of Glucan Synthase

Jennifer Nielsen Kahn, Guillermo García‐Effrón, Ming‐Jo Hsu et al. · Antimicrobial Agents and Chemotherapy · 2007 · 118 citations · Full text

PAP Inhibitor with In Vivo Efficacy Identified by Candida albicans Genetic Profiling of Natural Products

Bo Jiang, Deming Xu, John Allocco et al. · Chemistry & Biology · 2008 · 82 citations

, , +9

Caspofungin Susceptibility in <i>Aspergillus</i> and Non- <i>Aspergillus</i> Molds: Inhibition of Glucan Synthase and Reduction of β- <scp>d</scp> -1,3 Glucan Levels in Culture

Jennifer Nielsen Kahn, Ming‐Jo Hsu, Fred Racine et al. · Antimicrobial Agents and Chemotherapy · 2006 · 61 citations · Full text

, , +14

Mutations in Ribosomal Protein L10e Confer Resistance to the Fungal-specific Eukaryotic Elongation Factor 2 Inhibitor Sordarin

Michael Justice, Theresa Ku, Ming‐Jo Hsu et al. · Journal of Biological Chemistry · 1999 · 57 citations · Full text

Rows per page

1–5 of 10